Li X - Search Results

1

Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma.

Fan F, Gao J, Zhao Y, Wang J, Meng L, Ma J, Li T, Han H, Lai J, Gao Z, Li X, Guo R, Cao Z, Zhang Y, Zhang X, Chen H. Fan F, et al. Among authors: li t, li x. Cancer Res. 2023 Aug 15;83(16):2690-2703. doi: 10.1158/0008-5472.CAN-22-3140. Cancer Res. 2023. PMID: 37249584 Free PMC article.

2

Prognostic Factors for Survival of Stage IB Non-small Cell Lung Cancer Patients: A 10-Year Follow-Up Retrospective Study.

Yang Z, Li X, Bai J, Li D, Ma Z, Deng C, Fu F, Zhang Y. Yang Z, et al. Among authors: li d, li x. Ann Surg Oncol. 2023 Nov;30(12):7481-7491. doi: 10.1245/s10434-023-14016-y. Epub 2023 Aug 3. Ann Surg Oncol. 2023. PMID: 37535274

3

Prognosis of unresected versus resected early-stage pulmonary carcinoid tumors ≤3 cm in size: A population-based study.

Li X, Fan F, Jia X, Yang L, He J, Tang Q, Cao W, Che J, Xu S. Li X, et al. Cancer Med. 2024 Jun;13(11):e7311. doi: 10.1002/cam4.7311. Cancer Med. 2024. PMID: 38855831 Free PMC article.

4

Ten-Year Follow-Up of Lung Cancer Patients with Resected Stage IA Invasive Non-Small Cell Lung Cancer.

Li X, Fan F, Yang Z, Huang Q, Fu F, Zhang Y, Chen H. Li X, et al. Ann Surg Oncol. 2024 Sep;31(9):5729-5737. doi: 10.1245/s10434-024-15572-7. Epub 2024 Jun 18. Ann Surg Oncol. 2024. PMID: 38888859

5

Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data.

Xu S, Wang Y, Ren F, Li X, Ren D, Dong M, Chen G, Song Z, Chen J. Xu S, et al. Among authors: li x. Cancer Med. 2020 Oct;9(20):7686-7694. doi: 10.1002/cam4.3403. Epub 2020 Aug 28. Cancer Med. 2020. PMID: 32857918 Free PMC article.

6

Concurrent epidermal growth factor receptor T790M secondary mutation and epithelial-mesenchymal transition in a lung adenocarcinoma patient with EGFR-TKI drug resistance.

Xu S, Liu X, Liu R, Shi T, Li X, Zhong D, Wang Y, Chen G, Chen J. Xu S, et al. Among authors: li x. Thorac Cancer. 2017 Nov;8(6):693-697. doi: 10.1111/1759-7714.12484. Epub 2017 Aug 8. Thorac Cancer. 2017. PMID: 28786540 Free PMC article.

7

The Epidemiology of Ground Glass Opacity Lung Adenocarcinoma: A Network-Based Cumulative Meta-Analysis.

Li X, Ren F, Wang S, He Z, Song Z, Chen J, Xu S. Li X, et al. Front Oncol. 2020 Jul 21;10:1059. doi: 10.3389/fonc.2020.01059. eCollection 2020. Front Oncol. 2020. PMID: 32793469 Free PMC article.

8

Circular RNA Signature in Lung Adenocarcinoma: A MiOncoCirc Database-Based Study and Literature Review.

Zhao S, Li S, Liu W, Wang Y, Li X, Zhu S, Lei X, Xu S. Zhao S, et al. Among authors: li s, li x. Front Oncol. 2020 Oct 9;10:523342. doi: 10.3389/fonc.2020.523342. eCollection 2020. Front Oncol. 2020. PMID: 33163392 Free PMC article.

9

Lymph Node Metastases in Surgically Resected Solitary Ground-Glass Opacities: A Two-Center Retrospective Cohort Study and Pooled Literature Analysis.

Xu S, He Z, Li X, He J, Ni H, Ren D, Ren F, Li T, Chen G, Chen L, Chen J. Xu S, et al. Among authors: li t, li x. Ann Surg Oncol. 2023 Jun;30(6):3760-3768. doi: 10.1245/s10434-023-13235-7. Epub 2023 Mar 10. Ann Surg Oncol. 2023. PMID: 36897416

10

Serum microRNA-139-5p is downregulated in lung cancer patients with lytic bone metastasis.

Xu S, Yang F, Liu R, Li X, Fan H, Liu J, Wei S, Chen G, Chen J, Da Y. Xu S, et al. Among authors: li x. Oncol Rep. 2018 May;39(5):2376-2384. doi: 10.3892/or.2018.6316. Epub 2018 Mar 15. Oncol Rep. 2018. PMID: 29565453

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180,685 results

Search Page

Filters